Today Novartis announced that Omalizumab which has been used for Allergic Asthma, has been given an indication for chronic hives.
It has been approved for 12 years of age and older in people not responding to antihistamines. It has been dosed and 150 and 300 mg and has shown great efficacy. This is a very expensive drug, so there probably still will be barriers to prescribing it, but this will allow another treatment option for patients who have failed everything.
Stay tuned for more details.